Inflammation in AKI: Current understanding, key questions, and knowledge gaps

Journal of the American Society of Nephrology

Volumn 27, Issue 2, 2016, Pages 371-379

  Rabb, Hamid ^a   Griffin, Matthew D ^b   McKay, DIanne B ^c   Swaminathan, Sundararaman ^d   Pickkers, Peter ^e   Rosner, Mitchell H ^f   Kellum, John A ^e   Ronco, Claudio ^g  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 2; MICRORNA; PADGEM PROTEIN; PATTERN RECOGNITION RECEPTOR;

ACUTE KIDNEY FAILURE; ARTICLE; CYTOKINE RELEASE; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; KNOWLEDGE; KNOWLEDGE BASE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SEPSIS; ANIMAL; COMPLICATION; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; KIDNEY;

ACUTE KIDNEY INJURY; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; KIDNEY;

EID: 84970924677     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015030261     Document Type: Article

References (64)

1. Okusa MD, Rosner MH, Kellum JA, Ronco C: Acute DialysisQuality Initiative XIIIWorkgroup: Therapeutic Targets of Human AKI: Harmonizing Human and Animal AKI. J AmSoc Nephrol 27: 371-379, 2016
2. Medzhitov R: Inflammation 2010: New adventures of an old flame. Cell 140: 771-776, 2010
3. Linfert D, Chowdhry T, Rabb H: Lymphocytes and ischemia-reperfusion injury. Transplant Rev (Orlando) 23: 1-10, 2009
4. Ratliff BB, Rabadi MM, Vasko R, Yasuda K, Goligorsky MS: Messengers without borders: Mediators of systemic inflammatory response in AKI. J Am Soc Nephrol 24: 529-536, 2013
5. Chen GY, Nuñez G: Sterile inflammation: Sensing and reacting to damage. Nat Rev Immunol 10: 826-837, 2010
6. Kurts C, Panzer U, Anders HJ, Rees AJ: The immune system and kidney disease: Basic concepts and clinical implications. Nat Rev Immunol 13: 738-753, 2013
7. Anders HJ, Schaefer L: Beyond tissue injurydamage-associated molecular patterns, tolllike receptors, and inflammasomes also drive regeneration and fibrosis. J Am Soc Nephrol 25: 1387-1400, 2014
8. Kim HJ, Lee DW, Ravichandran K, O Keys D, Akcay A, Nguyen Q, He Z, Jani A, Ljubanovic D, Edelstein CL: NLRP3 inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injury. J Pharmacol Exp Ther 346: 465-472, 2013
9. Vallés PG, Lorenzo AG, Bocanegra V, Vallés R: Acute kidney injury: What part do toll-like receptors play? Int JNephrol RenovascDis 7: 241-251, 2014
10. Bolisetty S, Agarwal A: Neutrophils in acute kidney injury: Not neutral any more. Kidney Int 75: 674-676, 2009
11. Nelson PJ, Rees AJ, Griffin MD, Hughes J, Kurts C, Duffield J: The renal mononuclear phagocytic system. J Am Soc Nephrol 23: 194-203, 2012
12. Bajwa A, Kinsey GR, Okusa MD: Immune mechanisms and novel pharmacological therapies of acute kidney injury. Curr Drug Targets 10: 1196-1204, 2009
13. GramsME, Rabb H: The Distant organ effects of acute kidney injury. Kidney Int 81: 942-948, 2012
14. Linkermann A, Chen G, Dong G, Kunzendorf U, Krautwald S, Dong Z: Regulated cell death in AKI. J Am Soc Nephrol 25: 2689-2701, 2014
15. Carlin LM, Stamatiades EG, Auffray C, Hanna RN, Glover L, Vizcay-Barrena G, Hedrick CC, Cook HT, Diebold S, Geissmann F: Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell 153: 362-375, 2013
16. Awad AS, Rouse M, Huang L, Vergis AL, Reutershan J, Cathro HP, Linden J, Okusa MD: Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int 75: 689-698, 2009
17. Li L, Huang L, Sung SS, Lobo PI, Brown MG, Gregg RK, Engelhard VH, OkusaMD: NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury. J Immunol 178: 5899-5911, 2007
18. Renner B, Strassheim D, Amura CR, Kulik L, Ljubanovic D, Glogowska MJ, Takahashi K, Carroll MC, Holers VM, Thurman JM: B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion. J Immunol 185: 4393-4400, 2010
19. Zhang ZX,Wang S, Huang X,MinWP, Sun H, LiuW,Garcia B, Jevnikar AM:NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. J Immunol 181: 7489-7498, 2008
20. Gandolfo MT, Jang HR, Bagnasco SM, Ko GJ, Agreda P, Satpute SR, CrowMT, King LS, Rabb H: Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 76: 717-729, 2009
21. Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, Ju ST, Okusa MD: Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 20: 1744-1753, 2009
22. Kim MG, Koo TY, Yan JJ, Lee E, Han KH, Jeong JC, Ro H, Kim BS, Jo SK, Oh KH, Surh CD, Ahn C, Yang J: IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells. JAm Soc Nephrol 24: 1529-1536, 2013
23. Zhang MZ, Yao B, Yang S, Jiang L, Wang S, Fan X, Yin H, Wong K, Miyazawa T, Chen J, Chang I, Singh A, Harris RC: CSF-1 signaling mediates recovery fromacute kidney injury. J Clin Invest 122: 4519-4532, 2012
24. Kulkarni OP, Hartter I, Mulay SR, Hagemann J, Darisipudi MN, Kumar Vr S, Romoli S, Thomasova D, Ryu M, Kobold S, Anders HJ: Toll-like receptor 4-induced IL-22 accelerates kidney regeneration. J Am Soc Nephrol 25: 978-989, 2014
25. Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, Ruhrberg C, Cantley LG: Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22: 317-326, 2011
26. Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121: 4210-4221, 2011
27. Kinsey GR, Li L, Okusa MD: Inflammation in acute kidney injury. Nephron, Exp Nephrol 109: e102-e107, 2008
28. Shigeoka AA, Holscher TD, King AJ, HallFW, Kiosses WB, Tobias PS, Mackman N, McKay DB: TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and-independent pathways. J Immunol 178: 6252-6258, 2007
29. Shigeoka AA, Mueller JL, Kambo A, Mathison JC, King AJ, Hall WF, Correia JS, Ulevitch RJ, Hoffman HM, McKay DB: An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J Immunol 185: 6277-6285, 2010
30. Shigeoka AA, Kambo A, Mathison JC, King AJ, Hall WF, da Silva Correia J, Ulevitch RJ, McKay DB: Nod1 and nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury. J Immunol 184: 2297-2304, 2010
31. Reilly M, Miller RM, Thomson MH, Patris V, Ryle P, McLoughlin L, Mutch P, Gilboy P, Miller C, BroekemaM, Keogh B,McCormack W, van deWetering de Rooij J: Randomized, double-blind, placebo-controlled, doseescalating phase I, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody. Clin Pharmacol Ther 94: 593-600, 2013
32. Day YJ, Huang L, Ye H, Linden J, Okusa MD: Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: Role of macrophages. Am J Physiol Renal Physiol 288: F722-F731, 2005
33. Bajwa A, Huang L, Ye H, Dondeti K, Song S, Rosin DL, Lynch KR, Lobo PI, Li L, OkusaMD: Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury. J Immunol 189: 2584-2596, 2012
34. Li L,Huang L, Ye H, Song SP, Bajwa A, Lee SJ, Moser EK, Jaworska K, Kinsey GR, Day YJ, Linden J, Lobo PI, Rosin DL, Okusa MD: Dendritic cells tolerized with adenosine A?AR agonist attenuate acute kidney injury. J Clin Invest 122: 3931-3942, 2012
35. Yang SH, Lee JP, Jang HR, Cha RH, Han SS, Jeon US, Kim DK, Song J, Lee DS, Kim YS: Sulfatide-reactive natural killer T cells abrogate ischemia-reperfusion injury. J Am Soc Nephrol 22: 1305-1314, 2011
36. Jang HR, Gandolfo MT, Ko GJ, Satpute SR, Racusen L, Rabb H: B cells limit repair after ischemic acute kidney injury. J Am Soc Nephrol 21: 654-665, 2010
37. Jang HR, Rabb H: Immune cells in experimental acute kidney injury. Nat Rev Nephrol 11: 88-101, 2015
38. Molitoris BA: Therapeutic translation in acute kidney injury: The epithelial/endothelial axis. J Clin Invest 124: 2355-2363, 2014
39. Yalavarthy R, Edelstein CL: Therapeutic and predictive targets of AKI. Clin Nephrol 70: 453-463, 2008
40. Tábara LC, Poveda J,Martin-ClearyC, Selgas R, Ortiz A, Sanchez-Niño MD: Mitochondriatargeted therapies for acute kidney injury. Expert Rev Mol Med 16: e13, 2014
41. Lorenzen JM, Kaucsar T, Schauerte C, Schmitt R, Rong S, Hübner A, Scherf K, Fiedler J,Martino F, Kumarswamy R, Kölling M, Sörensen I, Hinz H, Heineke J, van Rooij E, Haller H, ThumT: MicroRNA-24 antagonism prevents renal ischemia reperfusion injury. J Am Soc Nephrol 25: 2717-2729, 2014
42. Lee CG, Kim JG, Kim HJ, Kwon HK, Cho IJ, Choi DW, Lee WH, Kim WD, Hwang SJ, Choi S, Kim SG: Discovery of an integrative network of microRNAs and transcriptomics changes for acute kidney injury. Kidney Int 86: 943-953, 2014
43. Anders H, Schlöndorff D: Murine models of renal disease: Possibilities and problems in studies using mutant mice. Exp Nephrol 8: 181-193, 2000
44. Becker GJ, Hewitson TD: Animal models of chronic kidney disease: Useful but not perfect. Nephrol Dial Transplant 28: 2432-2438, 2013
45. Kennedy SE, Erlich JH: Murine renal ischaemia-reperfusion injury. Nephrology (Carlton) 13: 390-396, 2008
46. Luther T, Flössel C, Mackman N, Bierhaus A, KasperM, Albrecht S, Sage EH, Iruela-Arispe L, Grossmann H, Ströhlein A, Zhang Y, Nawroth PP, Carmeliet P, Loskutoff DJ, Müller M: Tissue factor expression during human and mouse development. Am J Pathol 149: 101-113, 1996
47. Mestas J, Hughes CC: Of mice and not men: Differences between mouse and human immunology. J Immunol 172: 2731-2738, 2004
48. Giraud S, Favreau F, Chatauret N, Thuillier R, Maiga S, Hauet T: Contribution of large pig for renal ischemia-reperfusion and transplantation studies: The preclinical model. J Biomed Biotechnol 2011: 532127, 2011
49. Lieberthal W, Nigam SK: Acute renal failure. II. Experimentalmodels of acute renal failure: Imperfect but indispensable. Am J Physiol Renal Physiol 278: F1-F12, 2000
50. Doi K, Leelahavanichkul A, Yuen PS, Star RA: Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest 119: 2868-2878, 2009
51. Ganopolsky JG, Castellino FJ: A protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture model. Am J Pathol 165: 1433-1446, 2004
52. Leelahavanichkul A, Huang Y, Hu X, Zhou H, Tsuji T, Chen R, Kopp JB, Schnermann J, Yuen PS, Star RA: Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1. Kidney Int 80: 1198-1211, 2011
53. Kinasewitz GT, Chang AC, Peer GT, Hinshaw LB, Taylor FB Jr. : Peritonitis in the baboon: A primate model which stimulates human sepsis. Shock 13: 100-109, 2000
54. Tadagavadi RK, Reeves WB: Renal dendritic cells ameliorate nephrotoxic acute kidney injury. J AmSoc Nephrol 21: 53-63, 2010
55. Jo SK, Rosner MH, Okusa MD: Pharmacologic treatment of acute kidney injury: Why drugs haven'tworkedandwhat isonthe horizon. Clin J Am Soc Nephrol 2: 356-365, 2007
56. Molitoris BA, Okusa MD, Palevsky PM, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Faubel SG, Kellum JA,Wald R, ChertowGM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chinchilli VM, Liu KD, Cheung AK,Weisbord SD, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA: Design of clinical trials in AKI: A report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings. Clin J Am Soc Nephrol 7: 856-860, 2012
57. Okusa MD, Molitoris BA, Palevsky PM, Chinchilli VM, Liu KD, Cheung AK,Weisbord SD, Faubel S, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA: Design of clinical trials in acute kidney injury: A report from an NIDDK workshop-prevention trials. Clin J Am Soc Nephrol 7: 851-855, 2012
58. Gammelager H, Christiansen CF, Johansen MB, Tønnesen E, Jespersen B, Sørensen HT: Five-year risk of end-stage renal disease among intensive care patients surviving dialysis-requiring acute kidney injury: A nationwide cohort study. Crit Care 17: R145, 2013
59. Bihorac A, Chawla LS, Shaw AD, Al-Khafaji A, Davison DL, Demuth GE, Fitzgerald R, Gong MN, Graham DD, Gunnerson K, Heung M, Jortani S, Kleerup E, Koyner JL, Krell K, Letourneau J, Lissauer M, Miner J, Nguyen HB, Ortega LM, Self WH, Sellman R, Shi J, Straseski J, Szalados JE, Wilber ST, Walker MG, Wilson J, Wunderink R, Zimmerman J, Kellum JA: Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 189: 932-939, 2014
60. Macedo E, Mehta RL: Measuring renal function in critically ill patients: Tools and strategies for assessing glomerular filtration rate. Curr Opin Crit Care 19: 560-566, 2013
61. Pickkers P, Heemskerk S, Schouten J, Laterre PF, Vincent JL, Beishuizen A, Jorens PG, Spapen H, Bulitta M, Peters WH, van der Hoeven JG: Alkaline phosphatase for treatment of sepsis-induced acute kidney injury:A prospective randomized double-blind placebocontrolled trial. Crit Care 16: R14, 2012
62. Liotta M, Olsson D, Sartipy U, Holzmann MJ: Minimal changes in postoperative creatinine values and early and late mortality and cardiovascular events after coronary artery bypass grafting. Am J Cardiol 113: 70-75, 2014
63. Kalantarinia K, Okusa MD: Ultrasound contrast agents in the study of kidney function in health and disease. Drug Discov Today Dis Mech 4: 153-158, 2007
64. Marshall JC: Why have clinical trials in sepsis failed? Trends Mol Med 20: 195-203, 2014